Developing an Online Infrastructure to Enhance Model Accessibility and Validation: The Peer Models Network

Affiliations

¹ Faculty of Pharmaceutical Sciences, University of British Columbia, Room 4103 Pharmaceutical Sciences Building, 2405 Wesbrook Mall, Vancouver, BC, V6T 1Z3, Canada. harvards@mail.ubc.ca.
² Faculty of Pharmaceutical Sciences, University of British Columbia, Room 4103 Pharmaceutical Sciences Building, 2405 Wesbrook Mall, Vancouver, BC, V6T 1Z3, Canada.
³ Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, 588-1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada.
⁴ Sauder School of Business, University of British Columbia, 2053 Main Mall, Vancouver, BC, V6T 1Z2, Canada.
⁵ School of Communication, Simon Fraser University, K9671-8888 University Drive, Burnaby, BC, V5A 1S6, Canada.
⁶ , British Columbia, Canada.

Stephanie Harvard et al. Pharmacoeconomics. 2022 Oct.

. 2022 Oct;40(10):1005-1009.

doi: 10.1007/s40273-022-01179-x. Epub 2022 Jul 30.

¹ Faculty of Pharmaceutical Sciences, University of British Columbia, Room 4103 Pharmaceutical Sciences Building, 2405 Wesbrook Mall, Vancouver, BC, V6T 1Z3, Canada. harvards@mail.ubc.ca.
² Faculty of Pharmaceutical Sciences, University of British Columbia, Room 4103 Pharmaceutical Sciences Building, 2405 Wesbrook Mall, Vancouver, BC, V6T 1Z3, Canada.
³ Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, 588-1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada.
⁴ Sauder School of Business, University of British Columbia, 2053 Main Mall, Vancouver, BC, V6T 1Z2, Canada.
⁵ School of Communication, Simon Fraser University, K9671-8888 University Drive, Burnaby, BC, V5A 1S6, Canada.
⁶ , British Columbia, Canada.

No abstract available

References

1. Sampson CJ, Arnold R, Bryan S, Clarke P, Ekins S, Hatswell A, et al. Transparency in decision modelling: what, why, who and how? Pharmacoeconomics. 2019;37(11):1355–69. https://doi.org/10.1007/s40273-019-00819-z . - DOI - PubMed - PMC
1. Carlson JJ, Walton SM, Basu A, Chapman RH, Campbell JD, McQueen RB, et al. Achieving appropriate model transparency: challenges and potential solutions for making value-based decisions in THE United States. Pharmacoeconomics. 2019;37(11):1321–7. https://doi.org/10.1007/s40273-019-00832-2 . - DOI - PubMed - PMC
1. Harvard S, Werker GR, Silva DS. Social, ethical, and other value judgments in health economics modelling. Soc Sci Med. 2020;253: 112975. https://doi.org/10.1016/j.socscimed.2020.112975 . - DOI - PubMed
1. Elliott KC. A taxonomy of transparency in science. In: McCullagh M, editor. Canadian Journal of philosophy. Cambridge: Cambridge University Press; 2020. pp. 1–14. https://doi.org/10.1017/can.2020.21 .
1. Eddy DM, Hollingworth W, Caro JJ, Tsevat J, McDonald KM, Wong JB; ISPOR-SMDM Modeling Good Research Practices Task Force. Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force—7. Value Health. 2012;15(6):843–50. https://doi.org/10.1016/j.jval.2012.04.012 .